DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,071 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $107,850 | -1.7% | 431,661 | -1.8% | 0.28% | -4.5% |
| Q1 2024 | $109,750 | -8.3% | 439,492 | -15.0% | 0.29% | -12.3% |
| Q4 2023 | $119,655 | -12.8% | 517,227 | -6.8% | 0.33% | -20.7% |
| Q3 2023 | $137,251 | +4.7% | 555,245 | +1.6% | 0.42% | +3.4% |
| Q2 2023 | $131,108 | +156.0% | 546,284 | +168.8% | 0.41% | +128.1% |
| Q1 2023 | $51,218 | -6.7% | 203,214 | -1.7% | 0.18% | -9.2% |
| Q4 2022 | $54,895 | -99.9% | 206,823 | +1.9% | 0.20% | -4.9% |
| Q3 2022 | $52,399,000 | -20.9% | 202,869 | -22.3% | 0.21% | -18.6% |
| Q2 2022 | $66,233,000 | -10.0% | 261,253 | +4.2% | 0.25% | -1.2% |
| Q1 2022 | $73,577,000 | +12.4% | 250,831 | +26.1% | 0.26% | +16.9% |
| Q4 2021 | $65,468,000 | -13.5% | 198,984 | -19.9% | 0.22% | -22.1% |
| Q3 2021 | $75,658,000 | -1.6% | 248,518 | -13.2% | 0.28% | +2.6% |
| Q2 2021 | $76,878,000 | +15.4% | 286,473 | -3.2% | 0.27% | -0.4% |
| Q1 2021 | $66,635,000 | -1.1% | 296,051 | -2.4% | 0.28% | -11.6% |
| Q4 2020 | $67,365,000 | +86.9% | 303,256 | +81.2% | 0.31% | +51.7% |
| Q3 2020 | $36,041,000 | +14.6% | 167,375 | -5.9% | 0.20% | -3.8% |
| Q2 2020 | $31,450,000 | +13.7% | 177,854 | -11.0% | 0.21% | -9.4% |
| Q1 2020 | $27,650,000 | +2.3% | 199,767 | +13.5% | 0.24% | +27.0% |
| Q4 2019 | $27,021,000 | +37.2% | 176,055 | +29.1% | 0.18% | +21.7% |
| Q3 2019 | $19,701,000 | +3.6% | 136,408 | +2.5% | 0.15% | -1.9% |
| Q2 2019 | $19,015,000 | -26.5% | 133,043 | -32.1% | 0.16% | -28.2% |
| Q1 2019 | $25,874,000 | -29.3% | 195,988 | -45.5% | 0.22% | -35.9% |
| Q4 2018 | $36,593,000 | -22.3% | 359,356 | -17.1% | 0.34% | -6.9% |
| Q3 2018 | $47,089,000 | +32.4% | 433,362 | +20.2% | 0.36% | +21.5% |
| Q2 2018 | $35,579,000 | -1.0% | 360,550 | -1.8% | 0.30% | -1.7% |
| Q1 2018 | $35,947,000 | -20.5% | 367,142 | -24.6% | 0.30% | -21.5% |
| Q4 2017 | $45,223,000 | +20.3% | 487,213 | +11.2% | 0.39% | +21.4% |
| Q3 2017 | $37,595,000 | +121.9% | 438,274 | +118.3% | 0.32% | +112.0% |
| Q2 2017 | $16,939,000 | -27.2% | 200,728 | -26.3% | 0.15% | -29.6% |
| Q1 2017 | $23,282,000 | +14.3% | 272,210 | +4.0% | 0.21% | +8.7% |
| Q4 2016 | $20,369,000 | +24.7% | 261,669 | +25.6% | 0.20% | +41.0% |
| Q3 2016 | $16,330,000 | -76.0% | 208,313 | -69.1% | 0.14% | -75.8% |
| Q2 2016 | $68,026,000 | -14.2% | 673,534 | -19.4% | 0.58% | -14.3% |
| Q1 2016 | $79,252,000 | +21.0% | 835,449 | +18.5% | 0.67% | +20.7% |
| Q4 2015 | $65,506,000 | +50.1% | 705,285 | +37.7% | 0.56% | +45.2% |
| Q3 2015 | $43,645,000 | +109.7% | 512,204 | +110.6% | 0.38% | +126.6% |
| Q2 2015 | $20,818,000 | -7.9% | 243,217 | -8.6% | 0.17% | -1.7% |
| Q1 2015 | $22,597,000 | +62.0% | 266,152 | +63.6% | 0.17% | +53.6% |
| Q4 2014 | $13,945,000 | +50.5% | 162,691 | +33.4% | 0.11% | +49.3% |
| Q3 2014 | $9,268,000 | -71.3% | 121,984 | -70.2% | 0.08% | -70.0% |
| Q2 2014 | $32,265,000 | -32.3% | 409,830 | -35.5% | 0.25% | -30.7% |
| Q1 2014 | $47,655,000 | -10.0% | 635,378 | -7.4% | 0.36% | -8.8% |
| Q4 2013 | $52,955,000 | +24.5% | 685,943 | +11.7% | 0.40% | +23.8% |
| Q3 2013 | $42,551,000 | -15.3% | 613,828 | -22.7% | 0.32% | -14.2% |
| Q2 2013 | $50,251,000 | – | 793,862 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |